Previouis CU Chemie Uetikon GmbH
is now Seqens International SAS
Offering a wide range of technologies, Seqens provide its clients custom manufacturing services as well as a large portfolio of APIs & intermediates. We offer our customers with an access to our network of 3 R&D centers, 4 pilot units and 12 cGMP manufacturing sites and 6 cGMP multi-purposes sites to ensure a smooth in-house scale-up from early clinical phases to the commercial stage.
Send an inquiry on p-methylbenzylamine to Seqens International SAS
